Data Health Partners, Inc.

Data Health Partners, Inc., often referred to as "Data Health," is a privately held digital therapeutics company founded in early 2022 and incorporated on September 8, 2022. The company is headquartered in Beverly Hills, California.

Data Health Partners, Inc. develops digital therapeutics with evidence-based behavioral technology. Its primary product is CompassCoach GPT™, an AI Chatbot wellness coaching application. This platform is powered by REBOOT, Data Health's proprietary goal mastery and data-driven outcome optimization technology, which integrates behavioral science methods to assist users with lifestyle challenges like diet and exercise, and to encourage medication adherence. CompassCoach GPT™ is offered through a software-as-a-service (SaaS) business model, and Data Health has entered into a revenue-sharing and marketing agreement with Premier-RX to integrate its application with pharmacy benefits and telehealth services. The REBOOT technology is supported by five granted patents and two pending patent applications.

Data Health Partners, Inc. operates as a patent assertion entity, evidenced by its litigation posture. The company has appeared as a plaintiff in one tracked patent infringement case and has no recorded appearances as a defendant. Its sole case was filed in the U.S. District Court for the District of Delaware, a common venue for patent litigation.

The company's notable litigation includes Data Health Partners, Inc. v. Teladoc Health, Inc., filed on February 13, 2023. In this suit, Data Health Partners alleges that Teladoc Health's Livongo diabetes management platform infringes several U.S. patents, including U.S. Patent No. 11,675,791 and U.S. Patent No. 11,144,554, which generally relate to systems and methods for tracking progression toward customized goals and optimizing goal progression. The technology at the center of the dispute involves applying behavioral science principles to chronic condition management through data collection, automated analysis, and user feedback. Data Health claims exclusive ownership of the asserted patents by assignment.